Metadata
Title
Smart biomarker sensing using advanced nanopore technology and artificial intelligence
Category
general
UUID
9cbde1c842ca4e3eb28bede88e4f08ba
Source URL
https://research.anu.edu.au/partner-with-us/technology-marketplace/smart-biomark...
Parent URL
https://research.anu.edu.au/partner-with-us/innovation-marketplace
Crawl Time
2026-03-11T02:00:42+00:00
Rendered Raw Markdown

Smart biomarker sensing using advanced nanopore technology and artificial intelligence

Source: https://research.anu.edu.au/partner-with-us/technology-marketplace/smart-biomarker-sensing-using-advanced-nanopore-technology Parent: https://research.anu.edu.au/partner-with-us/innovation-marketplace

Health and wellbeing

Physical sciences

A highly scalable, flexible and industrially viable process to fabricate solid-state nanopores in silicon dioxide, silicon oxynitride and multilayered membranes has been invented by researchers at The Australian National University (ANU). The novel method also incorporates an etching process which eliminates the need for the corrosive and toxic hydrofluoric (HF) acid currently used in nanopore fabrication. The invention allows to create more tunable devices as nanopores can be customised in their radius, depth (from 10 nm to a few microns) and a multitude of shapes. It can also customise cone opening angles from 3 to 110 degrees, which cannot be achieved with current known fabrication methods. This invention can be used to fabricate multilayered gated nanopore membranes, which have a plethora of advanced applications, and allows for new possibilities in a variety of fields including highly sensitive medical diagnostics and health monitoring.

Potential benefits

Figure 1: Workflow of detection of biomarkers using ANU's smart nanopore sensing technique.

Potential applications

Opportunity

ANU seeks a manufacturer of diagnostic platforms (or devices that include membranes) to refine the technology in return for an option/licence agreement. The technology is effective and requires minimal development to modify it to meet specific biomarker diagnostics at ultra-low concentrations.This can be facilitated through leveraging research grant schemes in internationally and nationally.

IP status

The IP is owned by ANU and is the subject of a patent application.

Key research team

Dr Riya Palchaudhuri

riya.palchaudhuri@anu.edu.au

+61 405 737 335